The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 09, 2024

Filed:

Jan. 12, 2022
Applicant:

Medtronic Ireland Manufacturing Unlimited Company, Dublin, IE;

Inventors:

Abhijeet Dubhashi, Cotati, CA (US);

Douglas Hettrick, Andover, MN (US);

Guo Xu, Santa Rosa, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 18/14 (2006.01); A61B 5/24 (2021.01); A61B 5/242 (2021.01); G01R 33/032 (2006.01); A61B 18/00 (2006.01); A61B 18/18 (2006.01); G01R 33/26 (2006.01); A61B 90/00 (2016.01); A61B 18/02 (2006.01); A61B 17/32 (2006.01);
U.S. Cl.
CPC ...
A61B 5/4052 (2013.01); A61B 5/24 (2021.01); A61B 5/242 (2021.01); A61B 5/6857 (2013.01); A61B 18/1492 (2013.01); G01R 33/032 (2013.01); A61B 18/18 (2013.01); A61B 18/1815 (2013.01); A61B 2017/320069 (2017.08); A61B 2018/0022 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00636 (2013.01); A61B 2018/00642 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/1435 (2013.01); A61B 2018/1807 (2013.01); A61B 2090/376 (2016.02); A61B 2090/378 (2016.02); A61B 2090/3735 (2016.02); G01R 33/26 (2013.01);
Abstract

Systems and methods for measuring the magnetic fields generated by renal nerves before and/or after neuromodulation therapy are disclosed herein. One method for measuring the magnetic field of target nerves during a neuromodulation procedure includes positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient near the target nerves, and detecting a measurement of the magnetic field generated by the target nerves. The method can further include determining, based on the measurement of the magnetic field, a location of the target nerves, a location of ablation at the target nerves, and/or a percentage the target nerves were ablated by delivered neuromodulation energy.


Find Patent Forward Citations

Loading…